India has more diabetic patients than almost any country on earth — and one of the most dangerous consequences of this epidemic is one that most patients never see coming. Literally.
Diabetic retinopathy is a condition where prolonged high blood sugar silently destroys the tiny blood vessels in the retina — the light-sensitive layer at the back of the eye. It develops without pain, without blurring, without any symptom at all — for years — while the damage accumulates. And when symptoms finally appear, the disease is often already at a stage that cannot be fully reversed.
The cruel irony is that diabetic retinopathy is one of the most preventable causes of blindness in the world. Patients who are screened annually, who have their retina checked with OCT imaging, and who receive timely treatment at the right stage almost never go blind from this condition. Those who do not are the ones who were never checked until it was too late.
This guide explains diabetic retinopathy completely — how diabetes damages the eye, what the four stages mean, why there are no symptoms until late, what treatment is available, and what every diabetic patient in Dehradun and across Uttarakhand must do to protect their vision.
OCT Imaging | Fellowship Retina Specialists | NABH Accredited | Dehradun
Get comprehensive eye care at Raahi Netradham with fellowship specialists, advanced diagnostics, and in-house treatment facilities.
Think of your retinal blood vessels as a garden irrigation system. When blood sugar is normal, the pipes are flexible and intact. When blood sugar stays high for years, the pipes become stiff, porous, and brittle. They leak. Some sections collapse. The garden — your retina — starts to dry out in some areas and flood in others. New pipes grow in to compensate, but they are poorly made and burst easily, flooding the whole system with blood.
Your retina — the paper-thin, light-sensitive layer lining the back of your eye — is one of the most metabolically active tissues in your body. It has an extraordinarily dense network of tiny blood vessels to supply it with the oxygen and nutrients it needs.
These blood vessels are exquisitely sensitive to blood sugar levels. When blood sugar stays elevated over months and years, it damages the walls of these tiny vessels in a process called non-enzymatic glycation — essentially, sugar molecules attach to and damage the vessel wall proteins.
Each of these changes corresponds to a stage of diabetic retinopathy — from the first microaneurysms visible only under specialist examination, to the catastrophic bleeding and detachment of advanced disease. The progression happens silently, over years, with no warning to the patient.
Microaneurysms — tiny balloon-like swellings in the retinal blood vessel walls — are visible on specialist examination. At this stage, the patient has absolutely no symptoms. Vision is completely normal. The microaneurysms represent the earliest detectable sign of retinal damage.
| Stage | What Is Happening | Symptoms | Treatment |
|---|---|---|---|
| Stage 1 — Mild NPDR | Microaneurysms only | None — vision completely normal | Blood sugar control + annual monitoring |
| Stage 2 — Moderate NPDR | More vessels affected; some leaking; hard exudates (lipid deposits) | None — vision still normal | Blood sugar + 6-monthly monitoring; treat DMO if present |
| Stage 3 — Severe NPDR | Many blocked vessels; retina signalling for new vessels | Usually none — sometimes mild blur | Laser or injections often recommended; close monitoring every 3-4 months |
| Stage 4 — Proliferative DR (PDR) | Abnormal new vessels growing; high risk of bleeding | Floaters, blurring, dark haze — often sudden | Panretinal laser (PRP) + anti-VEGF injections; vitrectomy if bleeding or detachment |
Stages 1, 2, and even Stage 3 produce NO symptoms. Patients in Stage 3 — which is already a serious, treatment-requiring stage — typically see normally, drive normally, and have no reason to suspect anything is wrong with their retina. This is why waiting for symptoms before getting your retina checked is the single most dangerous thing a diabetic patient can do.
This is the question patients ask most urgently once they understand the staging: "If my retina is being damaged, why can't I feel it?"
The answer lies in anatomy and evolution. The retina has no pain receptors — it cannot hurt. Early diabetic changes affect the peripheral retina first — the edges, away from the central macula that controls the sharp vision you use for reading and detail. The brain compensates for peripheral losses automatically. And even when macular oedema begins to develop, the initial fluid accumulation is often so subtle that vision testing does not catch it until the oedema is significant.
By the time a diabetic patient notices blurring, difficulty reading, or floaters — the disease has usually progressed to Stage 3 or Stage 4. The window for the easiest, most effective treatment has often already passed.
"14 saal se sugar hai. Doctor ne kabhi aankhon ki baat nahi ki — bas HbA1c aur blood pressure dekhte the. Ek baar routine mein checkup kiya Raahi mein — Dr. Mohit ne bola Stage 3 retinopathy hai. Mujhe bilkul kuch nahi pata tha. Na dard, na blurriness, kuch nahi. Laser treatment hua. Ab regular aata hoon. Sochta hoon — agar aur 2-3 saal nikal jaate toh kya hota?"
— Vijay Pratap Singh, 52, Haridwar ("I've had diabetes for 14 years. My doctor never talked about eyes — just HbA1c and blood pressure. Once I had a routine checkup at Raahi — Dr. Mohit said Stage 3 retinopathy. I had no idea. No pain, no blurriness, nothing. Laser treatment done. Now I come regularly. I think — if another 2-3 years had passed, what would have happened?")
Diabetic macular oedema (DMO) deserves special attention because it is the most frequent cause of significant vision loss in diabetic patients — and it can occur at any stage of retinopathy, not just in advanced disease.
The macula is the central 5mm zone of the retina responsible for all fine-detail vision — reading, recognising faces, driving, watching television. When diabetic blood vessel damage causes fluid to accumulate within the macula, the swelling distorts and blurs central vision.
Anti-VEGF intravitreal injections are the first-line treatment for centre-involving DMO — and they work remarkably well when started early. Medications like Avastin (bevacizumab), Accentrix (ranibizumab), and Eylea (aflibercept) are injected directly into the vitreous gel of the eye, where they block the growth factor driving abnormal vessel leakage. Most patients need monthly injections initially, with the frequency reducing as the condition stabilises.
Diabetic macular oedema can be completely invisible on direct examination — a doctor looking at the retina through a dilated pupil may see nothing abnormal while the OCT scan reveals significant fluid building in the macula. At Raahi Netradham, every diabetic patient has an OCT at every visit. This is not optional — it is the standard that catches DMO at the treatable stage.
Book your OCT-based retina screening at Raahi Netradham — Dr. Mohit Garg (FVRS) | Dr. Chintan Desai (FVRSSN)
Not all diabetic patients develop retinopathy at the same rate. These factors significantly accelerate the disease — and if you have any of them, you need more frequent monitoring, not less.
| Risk Factor | Why It Accelerates Damage | Action |
|---|---|---|
| Duration of diabetes | The longer you have had diabetes, the higher the cumulative retinal damage — even if blood sugar is currently controlled | Annual minimum from diagnosis; acknowledge the risk openly |
| Poor blood sugar control (HbA1c above 7.5%) | Every percentage point of HbA1c above target significantly increases risk and progression rate | Work with diabetologist — every 0.5% HbA1c reduction matters for eyes |
| High blood pressure (hypertension) | BP and blood sugar together damage retinal vessels far faster than either alone | Control both — target BP below 130/80 for diabetic patients |
| High cholesterol (dyslipidaemia) | Contributes to hard exudate deposits in the retina — particularly harmful at the macula | Statin therapy if indicated; lipid monitoring alongside diabetes |
| Pregnancy with diabetes | Retinopathy can progress rapidly during pregnancy — even in patients with previously mild disease | Check every trimester from the first antenatal appointment |
| Kidney disease (nephropathy) | Diabetic nephropathy and retinopathy share the same small vessel pathology — if one is present, check the other | Increase eye check frequency to every 6 months minimum |
| Anaemia | Reduced oxygen delivery worsens retinal ischaemia | Treat anaemia; flag to treating physician |
| Smoking | Compounds vascular damage and reduces retinal oxygen supply | Cessation support — smoking in diabetic patients is particularly harmful |
Diabetic retinopathy cannot be diagnosed without specialist equipment. A standard vision test at an optician does not detect it. Even a blood sugar measurement does not detect it. These are the tests that do:
| Investigation / Test | Details & Role in Detection |
|---|---|
| 1. OCT (Optical Coherence Tomography) Most Important | Creates a precise cross-sectional image of every layer of the macula, detecting diabetic macular oedema at its earliest, most treatable stage. Available in-house at Raahi Netradham. |
| 2. Dilated Fundus Examination | After dilating drops widen the pupil, the specialist examines the entire retina using a slit lamp and special lens. Microaneurysms, haemorrhages, hard exudates, new vessels, and disc changes are all visible. |
| 3. Fundus Photography | Retinal photographs are stored in the patient's record, allowing precise comparison at future visits to track and detect disease progression over time. |
| 4. Fluorescein Angiography | Dye injected into a vein flows through the retinal blood vessels, allowing detailed mapping of leakage, non-perfusion, and new vessel growth. Used when additional detail is needed beyond OCT. |
| 5. Visual Acuity | Measures how clearly you see with each eye. Reduced acuity indicates that DMO or other retinal changes are already affecting central vision. |
At Raahi Netradham, all of these investigations are available in-house. Every diabetic patient is assessed with OCT and dilated fundus examination at every visit. Patients from Dehradun, Haridwar, Rishikesh, Mussoorie, Tehri, and across Uttarakhand complete their full retinal workup in one building, in one visit.
The correct treatment for diabetic retinopathy depends entirely on the stage. Here is the complete treatment pathway:
At these stages, the most powerful treatment is not in the clinic — it is at home. Tight blood sugar control (HbA1c target below 7%), blood pressure management, lipid control, stopping smoking, and regular exercise have been proven to slow or even partially reverse early retinal changes.
Annual or 6-monthly monitoring at Raahi Netradham tracks whether the disease is stable, improving, or progressing — and determines when additional treatment is needed.
Anti-VEGF intravitreal injections are the gold-standard treatment for diabetic macular oedema. The medications — Avastin (bevacizumab), Accentrix (ranibizumab), or Eylea (aflibercept) — are injected directly into the vitreous of the eye under topical (drop) anaesthesia. The procedure takes 5 to 10 minutes. Most patients need monthly injections initially, reducing in frequency as the fluid resolves.
When diabetic retinopathy reaches Stage 3 (severe NPDR) or Stage 4 (proliferative DR), panretinal photocoagulation — retinal laser — is used to destroy peripheral retinal areas that are generating the signals driving abnormal new vessel growth. This significantly reduces the risk of vitreous haemorrhage and tractional detachment.
PRP is done in the clinic, in sessions of 15 to 20 minutes, without general anaesthesia. Multiple sessions are typically needed. The procedure permanently reduces peripheral vision in exchange for protecting central vision — a trade-off that is almost always the right one when the alternative is blindness from bleeding or detachment.
When abnormal diabetic new vessels bleed into the vitreous gel, vision may drop dramatically — sometimes to only light perception. Small haemorrhages may clear spontaneously over weeks to months. Dense haemorrhages, or those that do not clear, require pars plana vitrectomy — surgical removal of the blood-filled vitreous and treatment of the underlying retinal problem.
In advanced proliferative diabetic retinopathy, fibrovascular scar tissue grows on the retinal surface and contracts, pulling the retina away from its base. This tractional retinal detachment is a sight-threatening emergency requiring vitrectomy surgery. Dr. Mohit Garg and Dr. Chintan Desai perform this surgery in-house at Raahi Netradham using 23G, 25G, and 27G micro-incision vitrectomy systems — the same technology available at India's premier retina centres.
| Stage / Complication | Treatment | Available at Raahi Netradham |
|---|---|---|
| Mild-Moderate NPDR (Stage 1-2) | Blood sugar control + monitoring | ✓ OCT + dilated exam every 6-12 months |
| Diabetic Macular Oedema (any stage) | Anti-VEGF injections (Avastin/Accentrix/Eylea) | ✓ In-house injections, monthly initially |
| Severe NPDR / PDR (Stage 3-4) | Panretinal laser (PRP) + anti-VEGF | ✓ Argon laser in-house |
| Vitreous Haemorrhage | Observation or vitrectomy surgery | ✓ B-scan + 25G/27G vitrectomy in-house |
| Tractional Retinal Detachment | Vitrectomy surgery — urgent | ✓ Same-day or next-day surgery available |
| Patient Type | When to Start | Frequency |
|---|---|---|
| Type 2 diabetic — newly diagnosed | At time of diagnosis | Annually if no retinopathy found |
| Type 1 diabetic — newly diagnosed | Within 5 years of diagnosis | Annually once screening begins |
| Diabetic — no retinopathy detected | Ongoing | Every 12 months minimum |
| Mild-moderate NPDR detected | Already underway | Every 6-12 months |
| Severe NPDR — Stage 3 | Already underway | Every 3-4 months |
| Proliferative DR — active treatment | During treatment | Monthly or as directed |
| Diabetic macular oedema — on injections | During treatment | Monthly — OCT at every injection visit |
| Poorly controlled HbA1c (above 7.5%) | Immediately | Every 3-6 months — higher progression risk |
| Pregnant + diabetic | At first antenatal visit | Every trimester — more if retinopathy found |
If you have diabetes and have not had a dilated retina examination with OCT in the past 12 months — book today. Not next month. Not after your next HbA1c result. Today. Diabetic retinopathy does not wait for a convenient moment. And the stage you are in right now determines what treatment is available to you — or whether any treatment is still possible.
India has approximately 77 million diabetic patients — the second largest diabetic population in the world. Estimates suggest that between 15% and 25% of these patients have some degree of diabetic retinopathy — many of them undiagnosed.
In Uttarakhand specifically, several factors compound this risk:
Urbanisation of the Doon Valley and dietary changes have significantly increased Type 2 diabetes prevalence in Dehradun and surrounding towns.
In Tehri, Chamoli, Pauri, and the high Garhwal, access to specialist retinal screening has historically been almost non-existent.
Many patients in Uttarakhand first receive a diabetes diagnosis when they present with a complication — including visual symptoms from retinopathy.
Diabetologists and general physicians in Uttarakhand do not always refer diabetic patients for annual retinal screening, despite national guidelines recommending it.
Raahi Netradham was specifically built to close this gap. Through its clinical practice on Haridwar Bypass Road and through the Shree Om Foundation's rural eye camp programme across Garhwal, the team is actively working to reach diabetic patients before their retinopathy reaches the irreversible stage.
Dr. Mohit Garg (FVRS, Sri Sankaradeva Nethralaya) and Dr. Chintan Desai (FVRSSN, Sankara Nethralaya Chennai) lead diabetic retinopathy care at Raahi Netradham — with in-house OCT at every visit, argon laser for retinal photocoagulation, anti-VEGF injections, and 23G/25G/27G vitrectomy for advanced complications. Patients from Dehradun, Haridwar, Rishikesh, Mussoorie, Tehri, Roorkee, and across Uttarakhand receive the same standard of retinal care as Delhi's premier hospitals — without leaving the state.
The honest answer is: partially. The risk of developing diabetic retinopathy cannot be eliminated entirely in a patient with long-standing diabetes — but it can be dramatically reduced, and its progression can be stopped.
| Action Plan | Why It Matters |
|---|---|
| 1. Keep HbA1c below 7% | Every percentage point above target significantly increases the risk and rate of retinal damage. This is the single most powerful protective factor. |
| 2. Control blood pressure rigorously | Target below 130/80 mmHg. Hypertension and hyperglycaemia together are far more destructive than either alone. |
| 3. Manage cholesterol | Lipid-lowering therapy reduces the severity of hard exudates and may slow retinopathy progression. |
| 4. Annual retinal screening | Detects early disease when treatment is simplest and most effective. |
| 5. Stop smoking | Smoking compounds vascular damage in every organ, including the retina. |
| 6. Maintain a healthy weight | Obesity worsens insulin resistance and blood sugar control. |
| 7. Attend retinal follow-up appointments | Do not miss scheduled visits once retinopathy has been detected. |
The patients who lose significant vision from diabetic retinopathy are, in the vast majority of cases, those who were not screened, those who had poor long-term blood sugar control, and those who missed follow-up appointments when retinopathy was already present. Each of these factors is modifiable. Each is within the patient's and their doctor's control.